SCHEMBL3338293

SCHEMBL3338293

CN[C@@H](Cc1c[nH]cn1)C(=O)OC(c1ccccc1)c1ccccc1

nearest known ligand 0.34

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.34
KDM4E B2RXH2 1/20 0.34
LMNA P02545 1/20 0.34
HPGD P15428 1/20 0.34
KIF11 P52732 1/20 0.34
CRHBP P24387 1/20 0.34
CRHR2 Q13324 1/20 0.34
HTR1A P08908 2/20 0.33
ADRA1D P25100 2/20 0.33
ADRA1A P35348 2/20 0.33
ADRA1B P35368 2/20 0.33
KMT2A Q03164 1/20 0.33
MAPT P10636 3/20 0.33
RECQL P46063 1/20 0.33
HDAC6 Q9UBN7 4/20 0.33
HDAC1 Q13547 2/20 0.33
S1PR1 P21453 1/20 0.33
ESR1 P03372 1/20 0.33
ESR2 Q92731 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL3336817 0.99 ALDH1A1 (0.34) ALDH1A1KDM4ELMNAHPGDKIF11
SCHEMBL2059164 0.83 HDAC6 (0.36) ALDH1A1KMT2AHDAC6HDAC1
SCHEMBL12765185 0.83 HDAC6 (0.36) ALDH1A1KMT2AHDAC6HDAC1
SCHEMBL28287713 0.82 NLRP3 (0.32)
Hydrochloric Acid SCHEMBL9876601 0.82 HDAC6 (0.35) ALDH1A1HDAC6HDAC1
Hydrochloric Acid SCHEMBL3339175 0.82 HDAC6 (0.35) ALDH1A1HDAC6HDAC1
SCHEMBL3338015 0.82 MAPT (0.49) ALDH1A1KMT2AMAPTRECQLS1PR1
Hydrochloric Acid SCHEMBL3336871 0.81 MAPT (0.48) ALDH1A1KMT2AMAPTRECQLS1PR1
SCHEMBL28774335 0.81
SCHEMBL3335362 0.80 ROCK2 (0.40) MAPTS1PR1ESR1ESR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2202227-B1 NOVEL HISTIDINE DERIVATIVE NIPPON ZOKI PHARMACEUTICAL CO (JP) 2013-11-20 EP disclosed
US-8324261-B2 Histidine derivatives NIPPON ZOKI PHARMACEUTICAL CO., LTD. (JP) 2012-12-04 US disclosed
EP-2202227-A1 NOVEL HISTIDINE DERIVATIVE Nippon Zoki Pharmaceutical Co., Ltd. (JP) 2010-06-30 EP disclosed
US-20100152459-A1 NOVEL HISTIDINE DERIVATIVES NIPPON ZOKI PHARMACEUTICAL CO., LTD. (JP) 2010-06-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100152459-A1 NOVEL HISTIDINE DERIVATIVES HRH4, HNMT, HRH3 ALDH1A1 1985/4885KDM4E 3112/4885LMNA 4787/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.